SCHEMBL3625504

SCHEMBL3625504

COc1ccc2c(O)cc(-c3nc(C)cs3)nc2c1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.40
RAB9A P51151 4/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
NPC1 O15118 3/20 0.40
POLB P06746 2/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
HIF1A Q16665 1/20 0.40
ALDH1A1 P00352 3/20 0.39
GAA P10253 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
RECQL P46063 1/20 0.38
GFER P55789 1/20 0.38
KDM4E B2RXH2 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13637183 0.88 MAPT (0.42) MAPTRAB9ASMN1; SMN2NPC1POLB
SCHEMBL313767 0.88 MAPT (0.39) MAPTRAB9ASMN1; SMN2NPC1POLB
SCHEMBL12070947 0.86 KDM4E (0.41) MAPTRAB9ASMN1; SMN2NPC1POLB
SCHEMBL313693 0.86 CTSS (0.38) MAPTRAB9ASMN1; SMN2NPC1POLB
SCHEMBL312942 0.85 ALDH1A1 (0.35) MAPTRAB9ASMN1; SMN2NPC1POLB
SCHEMBL1232405 0.85 ALDH1A1 (0.35) MAPTRAB9ASMN1; SMN2NPC1POLB
SCHEMBL3671740 0.85 FPR2 (0.37) MAPTRAB9ASMN1; SMN2NPC1POLB
SCHEMBL7917644 0.84 SREBF2 (0.41) MAPTRAB9ASMN1; SMN2POLBALDH1A1
SCHEMBL996348 0.82 SMPD3 (0.47) MAPTRAB9ASMN1; SMN2NPC1GAA
SCHEMBL13637184 0.81 CYP3A4 (0.39) MAPTRAB9ASMN1; SMN2NPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010033466-A1 MACROCYCLIC INHIBITORS OF HEPATITIS C PROTEASE PHENOMIX CORPORATION (US) 2010-03-25 WO disclosed
WO-2009142842-A2 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2009-11-26 WO disclosed